US Corporate Distress Financial Stress SEC Filings — April 16, 2026

16-04-2026

CareDx announced a definitive agreement to divest its Lab Products business to EuroBio Scientific for $170 million in cash, expected to close by the end of Q3 2026, to sharpen focus on core Precision Medicine Testing Services and Patient/Digital Solutions. Preliminary Q1 2026 results show total revenue of approximately $118 million (+39% YoY), Testing Services revenue of approximately $91 million (+48% YoY), and Patient/Digital Solutions revenue of approximately $16 million (+33% YoY); however, Lab Products revenue declined 4% YoY to approximately $10 million. Testing Services volume grew 17% YoY to approximately 54,900, with cash, cash equivalents, and marketable securities at approximately $198 million as of March 31, 2026.

• ·CareDx to provide transition services to EuroBio Scientific for at least 6 months at EuroBio Scientific’s expense.
• ·EuroBio Scientific grants CareDx sole and exclusive perpetual right to distribute post-transplant monitoring IVD tests in North America.
• ·Transaction requires Swedish regulatory review.
• ·Q1 2026 earnings call scheduled for April 28, 2026.

16-04-2026

Lincoln Educational Services Corporation (Nasdaq: LINC) entered into an amended and restated revolving credit facility, increasing the aggregate principal amount from $60 million to $125 million, with a $10 million letter of credit sublimit and a $25 million accordion feature, maturing on April 11, 2031. This provides $65 million in additional liquidity to support growth initiatives. CEO Scott M. Shaw noted 19-20% student start growth in Q1 2026, underscoring successful strategy execution amid a strong balance sheet.

• ·Credit facility term of five years.
• ·Operates campuses under three brands since inception in 1946.
• ·Amended facility with Fifth Third Bank as administrative agent, joint lead arranger, and joint bookrunner.

16-04-2026

Katapult Holdings, Inc. entered into the Tenth Limited Waiver to its Amended and Restated Loan and Security Agreement on April 15, 2026, in response to defaults including failure to maintain Minimum Trailing Three-Month Net Originations as of March 31, 2026, and excess charge-offs in collateral leases exceeding thresholds. The waiver permanently excuses the existing default and prevents advance rate reductions. This marks the tenth such waiver since the original agreement dated June 12, 2025, signaling ongoing covenant compliance challenges.

• ·Previous waivers include: First (Sep 15, 2025), Second (Sep 29, 2025), Third (Oct 13, 2025), Fourth (Oct 20, 2025), Fifth (Oct 27, 2025), Sixth (Oct 29, 2025), First Amendment (Nov 2, 2025), Second Amendment (Dec 11, 2025), Seventh (Jan 15, 2026), Eighth (Feb 13, 2026), Ninth (Mar 9, 2026).

16-04-2026

Versus Systems Inc. entered into a Stock Purchase Agreement with ASPIS Cyber Technologies, Inc. on April 15, 2026, under which it will sell common stock for total cash proceeds of $1,700,000 at a price equal to 105% of the closing price on the day preceding closing, expected on or before May 14, 2026. The Company anticipates these proceeds will enable it to maintain at least $2,500,000 in stockholders’ equity through December 31, 2026. No declines or flat metrics reported.

• ·Closing date selected by ASPIS on or before May 14, 2026.
• ·Agreement governed by laws of the State of New York.

16-04-2026

Lumen Technologies, Inc. entered into a Revolving Credit Agreement dated April 14, 2026, as the borrower, with Bank of America, N.A. serving as Administrative Agent and Collateral Agent, and various lenders party thereto, arranged by BOFA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., Morgan Stanley Senior Funding, Inc., and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Bookrunners. Pricing under the facility is determined by the Total Net Leverage Ratio, with initial Applicable Margins of 2.75% for Term SOFR Loans and 1.75% for ABR Loans, tiering to 2.25%-3.00% and 1.25%-2.00% respectively across four levels, alongside Applicable Commitment Fees starting at 0.375% and ranging to 0.30%-0.40%. The agreement includes standard covenants, representations, events of default, and provisions for incremental commitments and extensions.

• ·Filing Date: April 16, 2026; Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
• ·Published CUSIP Numbers: Deal - 55024EAH8; Revolving Facility - 55024EAJ4
• ·ABR floor components: Federal Funds Rate + 0.50%, Term SOFR (1-month) + 1.00%, or 1.00%

16-04-2026

On April 13, 2026, XMax Inc. entered into Securities Purchase Agreements with 22 non-U.S. person investors to sell 462,500 shares of common stock at $6.705 per share for an aggregate $3,101,062.50 in a private placement exempt under Regulation S. The transaction is a material definitive agreement, with forms filed as Exhibit 10.1. No financial performance metrics or period comparisons are disclosed.

• ·Common stock par value: $0.001 per share
• ·Trading symbol: XWIN
• ·Exemption: Regulation S under Securities Act of 1933
• ·Filing signed by Xiaohua Lu on April 16, 2026

16-04-2026

GM Financial Consumer Automobile Receivables Trust 2026-2, a newly formed issuing entity, closed the issuance of $1,269,810,000 in asset-backed notes on April 15, 2026, secured by prime consumer automobile loan contracts (Receivables). The notes comprise Class A-1 ($218,350,000 at 3.826%), Class A-2-A ($375,400,000 at 4.05%), Class A-2-B ($100,000,000 floating rate), Class A-3 ($475,400,000 at 4.15%), Class A-4 ($60,170,000 at 4.22%), Class B ($20,900,000 at 4.44%), and Class C ($19,590,000 at 4.64%). The transaction involves AFS SenSub Corp. as depositor, AmeriCredit Financial Services, Inc. d/b/a GM Financial as sponsor and servicer, with underwriting led by J.P. Morgan Securities LLC.

• ·Closing Date: April 15, 2026
• ·Underwriting Agreement dated April 8, 2026
• ·Trust Agreement originally dated February 27, 2026, amended and restated April 15, 2026
• ·Indenture, Sale and Servicing Agreement, and Purchase Agreement all dated April 15, 2026
• ·GM Financial serves as Servicer and Custodian
• ·Clayton Fixed Income Services LLC as Asset Representations Reviewer

16-04-2026

On April 10, 2026, Nasdaq notified Fathom Holdings Inc. that its common stock (FTHM) bid price closed below the $1.00 per share minimum for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days until October 7, 2026, to regain compliance by achieving a $1.00 or higher bid price for at least 10 consecutive business days, with no immediate impact on current listing. Failure to comply could lead to delisting, though an additional 180-day period may be available if other standards are met.

• ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period.
• ·Eligibility for second 180-day period requires meeting other Nasdaq Capital Market standards except Bid Price Rule, and intent to cure via reverse stock split if needed.
• ·Company is evaluating options; no assurance of regaining compliance.

16-04-2026

Faraday Future Intelligent Electric Inc. amended its securities purchase agreement with Gold King Arthur Holding Limited, a purchaser designated by AIxCrypto Holdings Inc., increasing the total investment from $10 million to $12 million, consisting of $500,000 in common stock (1,923,077 shares at $0.26 per share) and $11.5 million in convertible Series C preferred stock. The amendment eliminates the anti-dilution true-up provision, replacing it with a warrant to purchase up to 1,000,000 shares of common stock at $1.50 per share (4-year term, exercisable after delivery of the 500th FX Super One vehicle), which the company views as favorable to existing stockholders. Proceeds will fund the EAI robotics business targeting 1,000 deliveries with positive contribution margin and FX Super One advancement in 2026.

• ·Per share purchase price revised to average closing price of 10 trading days prior to April 14, 2026 signing date: $0.26
• ·Warrant exercise price: $1.50 per share; term: 4 years
• ·Initial Agreement dated February 4, 2026
• ·AIxC pre-funded the $12 million on behalf of the investor

16-04-2026

AIxCrypto Holdings, Inc. amended its Entrusted Investment Agreement with GOLD KING ARTHUR HOLDING LIMITED (GKA) and Song Wang to expand the definition of FFAI Shares to include preferred stock, loans, debt, and convertible notes, while removing certain share charges and call options. Concurrently, the Securities Purchase Agreement with Faraday Future Intelligent Electric Inc. (FFAI) was amended and restated, increasing the subscription amount from $10 million to $12 million ($500,000 for Class A Common Stock and $11.5 million for 11,502 shares of Series C Convertible Preferred Stock at $0.26 per share equivalent), eliminating True-Up Shares in exchange for a warrant for 1,000,000 FFAI Class A shares, with the deal closing on April 15, 2026. A $2 million loan from GKA to FFAI at 10% interest was provided and subsequently terminated upon closing.

• ·Loan matures one year from funding date and is unsecured; terminated upon SPA closing.
• ·FFAI Warrant term: 4 years; exercisable after delivery of 500th FX Super One vehicle; beneficial ownership limit: 9.99%; aggregate issuance limit: 19.99% of outstanding Class A shares pre-SPA.
• ·Alternate Conversion option at lower of conversion price or max($0.13, prior day close).

16-04-2026

Evofem Biosciences, Inc. entered into a Fourth Amendment to its Securities Purchase Agreement, originally dated October 14, 2020, with Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund DE, L.P. on April 10, 2026. The amendment sets the maturity date for the convertible promissory notes to the earlier of six months after the effective date, a Change of Control, or any acceleration event, with no prepayment allowed in the first six months without Adjuvant's consent. No specific financial amounts or performance metrics were disclosed.

• ·Original Securities Purchase Agreement dated October 14, 2020
• ·Amendment filed as Exhibit 10.1
• ·Company address: 7770 Regents Road, Suite 113-618, San Diego, California 92122
• ·Registrant is not an emerging growth company

16-04-2026

PENN Entertainment, Inc. entered into a Third Amendment to its Second Amended and Restated Credit Agreement dated May 3, 2022, effective April 16, 2026, to refinance its Existing Revolving Credit Facility and Existing Term A Credit Facility. The amendment introduces new 2026 Refinancing Revolving Commitments and 2026 Refinancing Term A Commitments from designated 2026 Refinancing Lenders, with proceeds used to repay in full and terminate the existing facilities. Outstanding Letters of Credit continue under the amended agreement, and certain schedules to the Credit Agreement are updated.

• ·Previous amendments: First Amendment on February 15, 2024; Second Amendment on December 4, 2024.
• ·2026 Refinancing Commitments detailed on Schedule A (Revolving) and Schedule B (Term A), not specified in filing excerpt.
• ·Existing Revolving and Term A Lenders waive prepayment claims under Section 5.05.

16-04-2026

On April 10, 2026, Smart Powerr Corp. entered into a note purchase agreement with Streeterville Capital, LLC, issuing and selling a secured promissory note (A-1 Note) with an original principal of $1,050,000, including $50,000 original issue discount and $15,000 in expenses added to principal, for net proceeds of $1,000,000. The A-1 Note bears 8% annual interest, matures in 24 months, allows prepayment at 115% of outstanding balance, and grants the lender redemption rights up to $200,000 per month after six months, with trigger events potentially increasing the balance up to 25% and restrictive covenants limiting future financings. The agreement contemplates potential future issuances of an A-2 Note ($1,050,000 principal) and a B Note ($8,000,000 principal), secured by a subsidiary pledge, guaranty, and DACA.

• ·Maturity of A-1 Note: 24 months from issuance.
• ·Trigger Effect aggregate cap: 25%.
• ·Event of Default interest: lesser of 18% per annum or maximum permitted by law.
• ·Covenants restrict Restricted Issuances, liens on subsidiary assets, and agreements prohibiting securities issuance to lender.
• ·Security includes DACA, Guaranty from CREG Holdings, LLC, and Pledge of all membership interests in CREG Holdings, LLC.

16-04-2026

On April 16, 2026, Blue Owl Capital Corporation entered into a Tenth Supplemental Indenture with Deutsche Bank Trust Company Americas for $400,000,000 aggregate principal amount of 6.450% notes due September 15, 2028, bearing semi-annual interest commencing September 15, 2026. The net proceeds will be used to repay existing indebtedness, including portions of its senior secured revolving credit facility with $50 million commitments maturing August 26, 2027, and the remainder on November 22, 2029. The notes are direct, general unsecured obligations with covenants tied to the Investment Company Act.

• ·Notes redeemable prior to maturity at the greater of treasury rate plus 45 basis points or 100% principal, plus accrued interest.
• ·Revolving Credit Facility interest: term SOFR plus up to 1.775% (2.00% for 2027 commitments) or alternative base rate plus up to 0.775% (1.00% for 2027 commitments).
• ·Change of control repurchase event triggers offer to purchase notes at 100% principal plus accrued interest.
• ·Underwriting Agreement dated April 13, 2026, with Morgan Stanley & Co. LLC.

16-04-2026

TeraWulf Inc. (NASDAQ: WULF) closed its public offering of 54,510,000 shares of common stock at $19.00 per share on April 16, 2026, including the full exercise of the underwriters' option for an additional 7,110,000 shares, generating gross proceeds of $1,035,690,000. The net proceeds will fund construction costs for its planned data center campus in Hawesville, Kentucky, full repayment of its bridge credit facility, future site acquisitions, and general corporate purposes. Morgan Stanley served as lead bookrunning manager, with BofA Securities, Citigroup, TD Cowen, and Wells Fargo Securities as joint bookrunners.

• ·Offering made pursuant to prospectus supplement under effective shelf registration statement on Form S-3ASR.
• ·Citizens Capital Markets and Santander acted as co-managers; Cantor Fitzgerald as equity capital markets advisor.

16-04-2026

On April 14, 2026, Spyre Therapeutics, Inc. entered into an underwriting agreement with Jefferies LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C., and Guggenheim Securities, LLC for the public offering of 6,500,000 shares of common stock at $62.00 per share, plus a 30-day option for an additional 975,000 shares that was fully exercised on April 15, 2026. The offering closed on April 16, 2026, generating gross proceeds of approximately $463.5 million before underwriting discounts and expenses. The company intends to use the net proceeds to advance its inflammatory bowel disease and rheumatic disease programs, including preclinical studies, clinical trials, manufacturing, and Phase 3 readiness activities.

• ·Public offering price of $62.00 per share
• ·Underwriting agreement dated April 14, 2026, filed as Exhibit 1.1
• ·Shelf registration statement on Form S-3 (File No. 333-293600), effective February 27, 2026
• ·Final prospectus supplement filed with SEC on April 16, 2026
• ·Opinion on legality of issuance from Ropes & Gray LLP filed as Exhibit 5.1

16-04-2026

Netcapital Inc. (Nasdaq: NCPL, NCPLW) announced the appointment of Todd Violette as Chief Executive Officer by its Board of Directors to accelerate capital formation, expand platform reach, and build long-term shareholder value. Violette replaces Rich Wheeless, whose contract was terminated by the Board, and brings over 25 years of leadership experience in capital markets, fintech, and digital assets from roles including CEO of CloudCover International, AppYea Inc., and Vinergy. Board member Arnie Scott highlighted Violette's background as key to sharpening execution and supporting platform users.

• ·Filing date: April 16, 2026
• ·Investor contact: 800-460-0815, ir@netcapital.com

16-04-2026

ICF International, Inc. and ICF Consulting Group, Inc. entered into an Amended and Restated Credit Agreement dated April 10, 2026, amending the prior agreement from May 6, 2022, to provide a $600,000,000 revolving credit facility (including a $200,000,000 alternative currency sublimit), a $450,000,000 term loan facility, and a $400,000,000 delayed draw term loan facility, for total commitments of $1.45 billion. PNC Bank, National Association acts as Administrative Agent, Swingline Loan Lender, and Issuing Lender, with PNC Capital Markets LLC as Sole Bookrunner and Joint Lead Arranger. The agreement includes standard covenants, representations, and events of default.

• ·Filing date: April 16, 2026; Agreement effective date: April 10, 2026
• ·CUSIP Numbers: Revolving Credit 44925FAD8, Term Loan 44925FAE6, Delayed Draw Term Loan 44925FAF3
• ·Prior Existing Credit Agreement dated May 6, 2022, with amendments in 2023

16-04-2026

OppFi Inc., through subsidiaries including Opportunity Funding SPE V, LLC (Borrower) and Opportunity Financial, LLC, entered into Amendment No. 3 to the Second Amended and Restated Revolving Credit Agreement on April 10, 2026, amending the facility dated February 13, 2025. The amendment incorporates specific changes shown in a marked copy of the agreement attached as Exhibit A, with all prior liens and security interests ratified and reaffirmed. No Defaults or Events of Default exist post-amendment, and a Fourth Amended and Restated Fee Letter was executed concurrently.

• ·Effectiveness subject to receipt of executed Amendment, Fee Letter, true representations/warranties, no Default/Event of Default, and payment of invoiced expenses.
• ·Governed by New York law; executed in counterparts with electronic signatures permitted.

16-04-2026

ESCO Technologies Inc. entered into a Purchase Agreement dated April 15, 2026, with TBG AG to acquire the share capital of Megger Group Limited, involving cash consideration partially financed by new debt facilities and the issuance of Consideration Shares exempt from registration under Section 4(a)(2). A related Shareholder Agreement grants TBG AG board designation rights, transfer restrictions during a 12-month Restricted Period, standstill limits at 24.5% ownership, and other protections while above the Minimum Ownership Threshold. Financing includes a Commitment Letter with JPMorgan Chase Bank, N.A. for up to $1,500 million in Best Efforts Facilities, with backstop and bridge options to ensure transaction funding.

• ·Seller Designee board seat continues while Seller Holders maintain at least 50% of Consideration Shares.
• ·50% of Consideration Shares released from transfer restrictions six months after closing.
• ·Standstill limits Seller Holders to 24.5% beneficial ownership without Board consent.
• ·Proceeds from financing to fund cash consideration, refinance existing debt, transaction costs, and general corporate purposes.
• ·Transaction subject to regulatory approvals and integration risks as noted in forward-looking statements.

16-04-2026

HeartBeam, Inc. (NASDAQ: BEAT) announced a proposed underwritten public offering of common stock (or equivalents) by the company, with net proceeds intended for advancing commercialization of its FDA-cleared 12-lead synthesized ECG system, developing extended-wear patch and heart attack detection initiatives, enhancing AI capabilities, and general corporate purposes. Titan Partners, a division of American Capital Partners, is the sole bookrunner; the offering is subject to market conditions with no assurance of completion, size, or terms. The announcement references a shelf registration statement on Form S-3/A effective March 17, 2026.

• ·Shelf registration statement on Form S-3/A (File No. 333-293307) filed February 9, 2026, declared effective March 17, 2026.
• ·FDA clearance for arrhythmia assessment using 3D ECG technology in December 2024.
• ·FDA clearance for 12-Lead ECG synthesis software for arrhythmia assessment in December 2025.
• ·Over 20 issued patents related to technology enablement.

16-04-2026

Achieve Life Sciences announced a private placement of securities for gross proceeds up to $354 million, including $180 million upfront and up to an additional $174 million from milestone-driven warrants exercisable post-FDA approval of cytisinicline. The transaction is led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio Partners, Paradigm BioCapital Advisors, and Marshall Wace, with participation from other investors. In connection, Andrew D. Goldberg, MD was appointed CEO and board member effective post-closing, with Richard Stewart transitioning to board director; proceeds will fund a Phase 3 trial for cytisinicline in e-cigarette cessation, commercialization, and general purposes.

• ·Private placement closing expected April 17, 2026, subject to customary conditions
• ·FDA PDUFA date for cytisinicline NDA: June 20, 2026
• ·NDA submitted June 2025, accepted September 2025
• ·Accompanying warrants expire on the later of 20th business day post-FDA approval announcement or company notice date

16-04-2026

Aspire Biopharma Holdings, Inc. (ASBPW), a pharmaceutical preparations company formerly known as PowerUp Acquisition Corp., filed an 8-K on April 16, 2026, reporting entry into a material definitive agreement under Item 1.01 and amendments to articles of incorporation or bylaws or a change in fiscal year under Item 5.03. The filing includes financial statements and exhibits under Item 9.01. No specific financial metrics, performance changes, or period-over-period comparisons were disclosed in the available filing metadata.

16-04-2026

MeiraGTx Holdings plc (MGTX) announced entry into an Underwriting Agreement dated April 16, 2026, with BofA Securities, Inc. and Goldman Sachs & Co. LLC for the proposed offering of ordinary shares. The filing incorporates the agreement by reference, includes a legal opinion from Walkers (Cayman) LLP on share validity, and cautions on forward-looking statements regarding offering completion, proceeds use, and associated risks with no guaranteed outcomes.

• ·Filing includes Exhibits: 1.1 (Underwriting Agreement), 5.1 (Opinion of Walkers (Cayman) LLP), 23.1 (Consent), and 104 (XBRL Cover Page).

16-04-2026

VerifyMe, Inc., along with its wholly-owned subsidiary VRME Subsidiary Corp., entered into the First Amendment to the Agreement and Plan of Merger with Open World Ltd., effective as of April 13, 2026, and reported on April 15, 2026. The amendment extends the outside date for completing the merger from June 30, 2026, to August 31, 2026. This update follows the original Merger Agreement dated February 11, 2026, with the full text incorporated as Exhibit 2.1.

• ·Filing submitted on April 16, 2026, under Items 1.01 and 9.01 of Form 8-K.
• ·Merger involves Merger Sub merging with and into Open World, making Open World a wholly-owned subsidiary of VerifyMe.

16-04-2026

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced a registered direct offering of 825,085 shares of common stock (or pre-funded warrants) at $3.03 per share, expected to generate approximately $2.5 million in upfront gross proceeds, with potential additional $4.6 million if short-term warrants to purchase 1,650,170 shares at $2.78 are fully exercised, for total potential gross proceeds of up to $7.1 million. The offering closes on or about April 16, 2026, with net proceeds for working capital and general corporate purposes; however, there is no assurance the warrants will be exercised. H.C. Wainwright & Co. is the exclusive placement agent.

• ·Shelf registration statement on Form S-3 (File No. 333-288595) filed July 9, 2025, effective January 6, 2026.
• ·Short-term warrants immediately exercisable, expire 24 months after effective date of resale registration statement.
• ·Pipeline targets Gram-positive bacteria including C. difficile, MRSA, VRE, DRSP, and B. anthracis.

16-04-2026

Onfolio Holdings, Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) announced on April 16, 2026, that it entered into a $100 million Equity Purchase Facility Agreement with an institutional investor to provide flexible capital for working capital, acquisitions of cash-generative online businesses, and growth of its digital asset reserve. The facility supports the company's strategy of scaling AI-powered services, improving margins, and compounding value, building on its first positive EBITDA year in 2025. CEO Dominic Wells emphasized its role in accelerating acquisitions and integrating AI infrastructure.

16-04-2026

Cheetah Net Supply Chain Service Inc. entered into a Share Transfer Agreement on April 16, 2026, to acquire 100% of the shares of Super International Trading Limited, a Hong Kong-based company engaged in trading large-scale industrial equipment, for approximately $4.98 million in cash, including a $1.5 million refundable deposit. The agreement includes a three-year post-closing performance commitment requiring at least $10 million in annual revenue from the Target Company, with shortfall compensation from the seller and a five-year incentive for exceeding that threshold. Closing is expected within three months, subject to customary conditions including due diligence, regulatory approvals, and board consents.

• ·Upon closing, Cheetah Net will assume only liabilities reflected in the Target's financial statements or expressly disclosed and accepted.
• ·Share Transfer Agreement filed as Exhibit 10.1.

16-04-2026

Nightfood Holdings, Inc. (OTCQB: NGTF), operating as TechForce Robotics, announced a strategic Supply Agreement with NUWA Robotics Corp. and Hon Hai Precision Industry Co., Ltd. (Foxconn) on April 16, 2026, to shift from development and pilot programs to commercial deployment and scaling of its robotic platforms. TechForce will define commercial requirements and retain exclusive IP ownership, with NUWA providing engineering and Foxconn handling manufacturing. This partnership leverages Foxconn's global manufacturing expertise and NUWA's AI robotics capabilities to meet growing market demand.

• ·Pilot programs completed across hospitality and service environments.
• ·TechForce pilots validated performance, unit economics, and RaaS model.

16-04-2026

Southern First Bancshares, Inc. (NASDAQ: SFST) announced the pricing of an underwritten public offering of 1,050,000 shares of common stock at $54.00 per share, with aggregate gross proceeds of approximately $56.7 million before discounts and expenses. The underwriters received a 30-day option to purchase up to 157,500 additional shares, potentially increasing gross proceeds to $65.2 million if fully exercised. Net proceeds will support general corporate purposes, including organic growth, capital for its bank subsidiary, debt redemption, and working capital; the offering is expected to close on April 17, 2026.

• ·Southern First Bank is the second largest bank headquartered in South Carolina.
• ·Operates in Greenville, Columbia, and Charleston markets of South Carolina; Charlotte, Triangle and Triad regions of North Carolina; and Atlanta, Georgia.
• ·Piper Sandler & Co. serving as sole book-running manager; Keefe, Bruyette & Woods as co-manager.
• ·Shelf registration statement File No. 333-293279.

16-04-2026

Momentus Inc. entered into a securities purchase agreement for a $5 million private placement of 1,333,334 shares of common stock (or equivalents) at $3.75 per share with a new fundamental institutional investor, priced at-the-market under Nasdaq rules. Gross proceeds are expected to be approximately $5 million before deducting placement agent fees and expenses, with net proceeds for working capital and general corporate purposes. Closing is anticipated on or about April 15, 2026, subject to customary conditions.

• ·Placement agent: A.G.P./Alliance Global Partners
• ·Securities offered under Section 4(a)(2) of Securities Act and/or Regulation D exemption
• ·Company to file SEC registration statement for resale of shares and underlying pre-funded warrants

16-04-2026

Audax Private Credit Fund, LLC entered into a Senior Secured Credit Agreement dated April 10, 2026, providing a $275,000,000 revolving credit facility with JPMorgan Chase Bank, N.A. as Administrative Agent and Collateral Agent. Lead arrangers include PNC Bank, National Association and Pinnacle Bank d/b/a Synovus Bank. The facility supports the borrower's investment activities as a BDC and RIC, with no comparative performance data available.

• ·Agreement effective as of April 10, 2026; filed on April 16, 2026 via Form 8-K Items 1.01 and 2.03.
• ·Applicable Margin: 0.75% (ABR Loans) / 1.75% (other Loans) if Gross Borrowing Base >= 1.6x Combined Debt Amount; otherwise 0.875% / 1.875%.
• ·Affiliate Agreements: Investment advisory agreement with Audax PDB (April 10, 2025); Administration agreement with Audax Management Company (NY), LLC (April 10, 2025).

16-04-2026

John Hancock Comvest Private Income Fund, acting as Transferor and Servicer, along with borrower Comvest Senior Lending Fund LL1 SPV, LLC, entered into the Fifth Amendment to their Loan and Servicing Agreement on April 14, 2026, with Administrative Agent and Lender Sumitomo Mitsui Banking Corporation and Lender Webster Bank, N.A. The amendment modifies the agreement originally dated July 16, 2024, which provides for up to $445,000,000 in financing. The filing confirms no Events of Default, full compliance with covenants, and ratification of all prior terms without novation.

• ·Original Loan and Servicing Agreement dated July 16, 2024
• ·Fifth Amendment effective upon execution by Administrative Agent
• ·Governed by New York law with jury trial waiver

16-04-2026

On April 13, 2026, 1606 Corp. entered into the First Amendment to its Purchase and Sale Agreement with Jefferson Enterprise Energy, LLC, extending the closing date for the acquisition of real property and related assets in Angelina County, Texas, from April 15, 2026, to May 22, 2026. The total purchase price remains unchanged at $11,168,864, but the $250,000 earnest money deposit is now deemed fully earned by the Seller as a non-refundable extension fee and will not be credited against the purchase price. The Company must provide financial information upon the Seller's request to verify its ability to close.

• ·Original Purchase and Sale Agreement effective as of March 12, 2026
• ·Property location: Angelina County, Texas

16-04-2026

On April 14, 2026, Toyota Auto Finance Receivables LLC and Toyota Motor Credit Corporation entered into an underwriting agreement with several underwriters, including Mizuho Securities USA LLC and Barclays Capital Inc., for the issuance of asset-backed notes by Toyota Auto Receivables 2026-B Owner Trust totaling $1,900,000,000 across Classes A-1 ($400,600,000), A-2a ($537,900,000), A-2b ($134,400,000), A-3 ($672,300,000), A-4 ($107,300,000), and B ($47,500,000), with closing expected on April 21, 2026. The notes are secured by a pool of motor vehicle retail installment sales contracts (Receivables) with a cutoff date of February 28, 2026. Multiple related agreements, including the Sale and Servicing Agreement, Indenture, and Receivables Purchase Agreement, are to be executed on the closing date.

• ·Cutoff Date for Receivables: February 28, 2026
• ·Filing Date: April 16, 2026
• ·Date of Earliest Event Reported: April 14, 2026
• ·Expected Closing Date for Agreements and Note Issuance: April 21, 2026

16-04-2026

BMW Auto Leasing LLC and BMW Financial Services NA, LLC entered into an Underwriting Agreement on April 14, 2026, with J.P. Morgan Securities LLC for the issuance of $1,500,000,000 in asset-backed Notes by BMW Vehicle Lease Trust 2026-1, consisting of Class A-1 ($249,600,000), Class A-2a ($490,200,000), Class A-2b ($90,000,000), Class A-3 ($580,200,000), and Class A-4 ($90,000,000), to be issued on the Closing Date of April 22, 2026. The Notes are backed by a portfolio of retail auto lease contracts (Specified Leases) and related leased vehicles (Specified Vehicles) via a SUBI Certificate transferred through various agreements. The filing includes forms of multiple related agreements such as the Indenture, Servicing Supplement, and Transfer Agreements, with no performance metrics or comparisons provided.

• ·Notes interest rates: Class A-1 at 3.830%, Class A-2a at 4.03%, Class A-2b at Benchmark + 0.37%, Class A-3 at 4.15%, Class A-4 at 4.18%
• ·Asset class: Auto leases, with lease cut-off date after February 28, 2026
• ·Filing includes Depositor Certification (Exhibit 36.1) for shelf offerings of asset-backed securities

16-04-2026

Franklin BSP Capital Corporation, as collateral manager, entered into Amendment No. 5 to the Loan and Servicing Agreement dated April 10, 2026, increasing the maximum facility amount from $300,000,000 to $400,000,000 USD with FBLC Funding I, LLC as borrower and Wells Fargo Bank as administrative agent. This expansion provides additional borrowing capacity without any reported Termination Events. No declines or negative performance metrics are present in the filing.

• ·Effectiveness conditioned on payment of outstanding fees (if invoiced), delivery of opinion of counsel, and executed signature pages.
• ·No Unmatured Termination Event or Termination Event upon giving effect to the Amendment.
• ·Original agreement dated August 28, 2020, previously amended four times (April 6, 2021; May 27, 2022; August 25, 2023; August 30, 2024).